VCG
ELV icon

Vantage Consulting Group’s Elevance Health ELV Stock Holding History

Vantage Consulting Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-465
Closed -$252K – 60
2024
Q2 		$252K Sell
465
-40
-8% -$21.1K 0.19% 93
2024
Q1 		$262K Sell
505
-17
-3% -$8.46K 0.17% 94
2023
Q4 		$246K Sell
522
-67
-11% -$31K 0.17% 125
2023
Q3 		$256K Buy
589
+30
+5% +$13.6K 0.17% 101
2023
Q2 		$248K Sell
559
-40
-7% -$18.5K 0.14% 126
2023
Q1 		$275K Buy
599
+74
+14% +$35.2K 0.16% 96
2022
Q4 		$269K Sell
525
-67
-11% -$34K 0.16% 96
2022
Q3 		$269K Buy
592
+28
+5% +$13.4K 0.16% 96
2022
Q2 		$272K Buy
564
+4
+0.7% +$1.98K 0.15% 94
2022
Q1 		$275K Sell
560
-294
-34% -$134K 0.11% 101
2021
Q4 		$396K Sell
854
-114
-12% -$48K 0.11% 58
2021
Q3 		$361K Buy
968
+261
+37% +$99.2K 0.08% 61
2021
Q2 		$270K Buy
707
+143
+25% +$54.6K 0.05% 97
2021
Q1 		$202K Buy
564
+154
+38% +$49.5K 0.04% 89
2020
Q4 		$132K Buy
+410
New +$126K 0.01% 97

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vantage Consulting Group's ELV Position: Q3 2024 in Review

Vantage Consulting Group sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 465 shares — an estimated $252K sold.

Vantage Consulting Group first reported a position in ELV in Q4 2020 and held it in 15 quarters. The position peaked at $396K in Q4 2021. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Vantage Consulting Group reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 465 Elevance Health shares in Q3 2024, an estimated $252K.
  • Vantage Consulting Group first reported a position in Elevance Health in Q4 2020 and held it in 15 quarters.
  • Vantage Consulting Group's Elevance Health position peaked at $396K in Q4 2021.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.